Inhibin and ovarian cancer

Journal of Reproductive Immunology

Volumn 39, Issue 1-2, 1998, Pages 77-87

  Burger, H G ^b   Baillie, A ^b   Drummond, A E ^b   Healy, D L ^b   Jobling, T ^b   Mamers, P ^b   Robertson, D M ^b   Susil, B ^b   Cahir, N ^b   Shen, Y ^b   Verity, K ^b   Fuller, P J ^b   Groome, N P ^a   Findlay, J K ^b  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

Activin; CA125; Granulosa cell tumour; Inhibin; Mucinous tumour; Ovarian cancer; Serous cystadenocarcinoma

Indexed keywords

FOLLITROPIN RECEPTOR; INHIBIN; PROTEIN SUBUNIT;

CONFERENCE PAPER; CONTROLLED STUDY; CYSTADENOCARCINOMA; EPITHELIUM CELL; FEMALE; GENE MUTATION; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CANCER; PATIENT MONITORING; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; MIDDLE AGED; OVARIAN NEOPLASMS; RECEPTORS, FSH;

EID: 18144432285     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(98)00014-X     Document Type: Conference Paper

References (23)

1. Aittomäki K., Lucena J.L.D., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., Kaskikari R., Sankila E.M., Lehvaslaiho H., Engel A.R. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 82:1995;959-968.
2. Boggess J.F., Soules M.R., Goff B.A., Greer BE., Cain J.M, Tamimi H.K. Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol. Oncol. 64:1997;64-69.
3. Burger H.G. Inhibin. Reprod. Med. Rev. 1:1992;1-29.
4. Burger H.G., Fuller P.J. The inhibin/activin family and ovarian cancer. Trends Endocrinol. 7:1996;1-6.
5. Burger H.G., Robertson D.M., Cahir N., Mamers O., Healy D.L., Jobling T., Groome N. Characterisation of inhibin immunoreactivity in postmenopausal women with ovarian tumours. Clin. Endocrinol. 44:1996;413-418.
6. Groome N.P., O'Brien M. Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. J. Immunol. Methods. 165:1993;167-176.
7. Groome N.P., Illingworth P.J., O'Brien M., Priddle J., Weaver K., McNeilly A.S. Quantitation of inhibin Pro-αC-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab. 80:1996;2926-2932.
8. Groome N.P., Illingworth P.J., O'Brien M., Pal R., Rodger F.E., Mather J.P., McNeilly A.S. Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 81:1996;1401-1405.
9. Gurusinghe C.J., Healy D.L., Jobling T., Mamers P., Burger H.G. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol. Oncol. 57:1995;27-32.
10. Healy D.L., Burger H.G., Mamers P., Jobling T., Bangah M., Quinn M., Grant P., Day A.J., Rome R., Campbell J.J. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumours. N. Eng. J. Med. 329:1993;1539-1542.
11. Jobling T., Mamers P., Healy D.L., MacLachlan V., Burger H.G., Quinn M., Rome R., Day A.J. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol. Oncol. 55:1994;285-289.
12. Kotlar T.J., Young R.H., Albanese C., Crowley Jr W.F., Scully R.E., Jameson J.L. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J. Clin. Endocrinol. Metab. 82:1997;1020-1026.
13. LaPolt P.B., Soto D., Su J-G., Campen C.A., Vaughan J., Vale W., Hsueh A.J.W. Activin stimulation of inhibin secretion and messenger RNA levels in cultured granulosa cells. Mol. Endocrinol. 3:1989;1666-1673.
14. Lappohn R.E., Burger H.G., Bouma J., Bangah M., Krans M, de Bruijn H. Inhibin as a marker for granulosa cell tumors. New. Eng. J. Med. 321:1989;790-793.
15. Lyons J., Landis C.A., Harsh G., Vallar L., Grunewald K., Feichtinger H., Duh Q.Y., Clark O.H., Kawasaki E., Bourne H., Bourne H.R. Two G protein oncogenes in human endocrine tumors. Science. 249:1990;655-659.
16. Matzuk M.M., Finegold M.K., Su J.G., Hsueh A.J., Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:1992;313-319.
17. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5:1989;874-879.
18. Robertson D.M., Tsonis C.G., McLachlan R.I., Handelsman D.J., Leask R., Baird D.T., McNeilly A.S., Hayward S., Healy D.L., Findlay J.K., Burger H.G., deKretser D.M. Comparison of inhibin immunological and in vitro biological activities in human serum. J. Clin. Endocrinol. Metab. 67:1988;438-443.
19. Robertson D.M., Burger H.G., Sullivan J., Cahir N., Groome N.P., Poncelet E., Franchimont P., Woodruff T., Mather J.P. Biological and immunological characterisation of inhibin forms in human plasma. J. Clin. Endocrinol. Metab. 81:1996;669-676.
20. Robertson, D.M., Cahir, N., Pettersson, K., Burger, H.G., 1996. The development of a two-site immunofluorometric assay for serum inhibins and application to women with ovarian cancer. Proc. 39th Ann. Sci. Meet. Endocrine Society of Australia, Sydney, Australia, 29th September-2nd October, 1.
21. Robertson D.M., Cahir N., Findlay J.K., Burger H.G., Groome N.P. The biological and immunological characterisation of inhibin A and B forms in human follicular fluid and plasma. J. Clin. Endocrinol. Metab. 82:1997;889-895.
22. Shen Y., Mamers P., Jobling T., Burger H.G., Fuller P.J. Absence of the previously reported G-protein oncogene (gip2) in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab. 81:1996;4159-4161.
23. Vaughan J.M., Rivier J., Corrigan A.Z., McClintock R., Campen C.A., Jolley DI., Vogmayr J.K., Bardin C.W., Rivier C., Vale W. Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods Enzymol. 168:1989;588-617.